The major finding is both NAC and surgical intervention affect proportion of CCR2+ and CD163+ monocytes within non-classical CD14-CD16+ and CD14+CD16+ subsets in patients with CRC, and the effects are specific for colon and rectal cancer patients. This evidence concerns the gene CD163 and rectal cancer.